Verify Kratom Product Ingredients After New Federal Synthetic Rules
Federal agencies are targeting synthetic kratom compounds for scheduling while leaving natural leaf products alone, creating a need for consumer diligence.
Key points
- The DEA plans to schedule synthetic kratom derivatives as Schedule 1 controlled substances.
- Natural kratom leaves containing mitragynine will remain unscheduled under this proposal.
- Advocates support the move to distinguish safe natural products from dangerous synthetics.
The federal government is proposing new rules that would ban synthetic kratom derivatives while allowing the continued sale of natural kratom leaf products to consumers who use them.
In plain English
Kratom comes from the leaves of the Mitragyna speciosa tree. These leaves contain dozens of chemical compounds called alkaloids that affect the human body. Some of these compounds interact with opioid receptors in the brain, similar to how morphine works, particularly when taken in higher doses. At lower doses, kratom acts more like a stimulant rather than a depressant.
The primary active ingredients in natural kratom are mitragynine and 7-hydroxymitragynine. While mitragynine is abundant, 7-hydroxymitragynine makes up only about two percent of the total alkaloid content. This complexity is why distinguishing between natural plant material and synthesized versions is a focus of the new regulatory efforts.
The background
Kratom use has grown significantly in the United States in recent years. Survey data indicates that an estimated 1.7 million Americans aged 12 and older used kratom in 2021. A separate study from the University of Michigan, released earlier this May, found that roughly five million Americans have tried kratom at least once. This figure includes more than 100,000 children between the ages of 12 and 17.
Proponents argue that kratom can help manage chronic pain or serve as an alternative treatment for substance use disorders, particularly those involving opioids. However, the debate has intensified following high-profile deaths and injury reports linked to kratom products. These incidents have fueled calls for stricter regulation, though advocates have historically opposed blanket bans that would criminalize natural leaf products used by millions.
What changes now
The Drug Enforcement Administration, acting on advice from the U.S. Department of Health and Human Services, is planning to revise its definitions of when a kratom-based product can be considered a schedule 1 controlled substance. The new plan focuses specifically on outlawing synthetic kratom derivatives. Under this proposal, these synthetic compounds would be targeted for scheduling, making their manufacture, distribution, and possession illegal under federal law.
Mac Haddow, senior fellow on public policy for the American Kratom Association, stated that they are absolutely supportive of banning or scheduling these synthetics. This stance marks a shift from previous years of protests and legal battles. Advocates hope this targeted approach establishes a safe middle ground, protecting users of natural kratom while removing dangerous synthetic alternatives from the market. No final rule has been enacted yet.
Key terms explained
When regulators discuss scheduling substances, they are categorizing them based on medical use and potential for abuse. Schedule 1 implies no accepted medical use and high abuse potential. Synthetic derivatives are chemically created versions of natural compounds, often designed to be more potent or bypass legal restrictions. Teams usually check vendor transparency; verify that products list specific alkaloid content. Look for third-party lab testing results that confirm the absence of unauthorized synthetic additives. Ensure your supply chain partners understand the difference between natural leaf extraction and chemical synthesis.
Background: Supply chain attacks
Supply chain attacks compromise your systems indirectly. An adversary infiltrates a trusted vendor or software update. When you install that legitimate-looking update, the malware executes inside your network. This method bypasses perimeter defenses because the code carries a valid digital signature from a reputable source.
Read the full guide: What Is Supply Chain Attacks: How Indirect Compromise Works
What to do and how to stay safe: DEA
- Review product labels to confirm they specify natural leaf origin rather than synthesized compounds.
- Check for third-party laboratory testing certificates that verify the absence of synthetic alkaloids.
- Monitor federal register updates for the final implementation date of the new scheduling rules.
- Consult with healthcare providers before using kratom products to manage pain or substance use disorders.
General security guidance from the Vector Update newsroom. It is not confirmed advice from the organisations named in this story.
Frequently asked questions
Will natural kratom be banned under this new proposal?
No, the DEA is specifically targeting synthetic kratom derivatives, leaving natural leaf products unscheduled.
How many people use kratom in the United States?
An estimated 1.7 million Americans aged 12 and older used kratom in 2021, with roughly five million having tried it in their lifetime.
Do kratom advocates support these new regulations?
Yes, the American Kratom Association supports banning synthetic derivatives while protecting the legal status of natural kratom.
